| Income Statement |
| Total Revenue | 913.69M |
|
| Revenues (USD) | 913.69M |
| Cost of Revenue | 582.20M |
| Gross Profit | 331.48M |
| Operating Expenses | 171.97M |
| Research and Development Expense | 24.18M |
| Selling, General and Administrative Expense | 146.88M |
| Operating Income | 159.51M |
| Interest Expense | 9.94M |
| Income Tax Expense | 29.58M |
| Net Income | 128.19M |
| Net Income Common Stock | 128.19M |
| Net Income Common Stock (USD) | 128.19M |
| Consolidated Income | 128.19M |
| Earnings per Basic Share | 3.47 |
| Earnings per Basic Share (USD) | 3.47 |
| Earnings per Diluted Share | 3.46 |
| Dividends per Basic Common Share | 0.24 |
| Earning Before Interest & Taxes (EBIT) | 167.71M |
| Earning Before Interest & Taxes (USD) | 167.71M |
| Weighted Average Shares | 36.90M |
| Weighted Average Shares Diluted | 37.06M |
| Balance Sheet |
| Cash and Equivalents | 343.45M |
| Cash and Equivalents (USD) | 343.45M |
| Trade and Non-Trade Receivables | 996.33M |
| Current Assets | 2.07B |
| Property, Plant & Equipment Net | 590.40M |
| Total Assets | 5.27B |
| Debt Current | 200.00M |
| Total Debt | 1.15B |
| Current Liabilities | 1.36B |
| Debt Non-Current | 948.38M |
| Total Liabilities | 2.64B |
| Accumulated Retained Earnings (Deficit) | 4.43B |
| Accumulated Other Comprehensive Income | -194.03M |
| Shareholders Equity | 2.63B |
| Shareholders Equity (USD) | 2.63B |
| Assets Non-Current | 3.20B |
| Total Debt (USD) | 1.15B |
| Deferred Revenue | 568.97M |
| Goodwill and Intangible Assets | 2.20B |
| Inventory | 640.64M |
| Liabilities Non-Current | 1.28B |
| Trade and Non-Trade Payables | 277.21M |
| Tax Liabilities | 159.56M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 28.37M |
| Net Cash Flow from Financing | -8.01M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -27.90M |
| Capital Expenditure | -11.52M |
| Issuance (Purchase) of Equity Shares | -8.01M |
| Net Cash Flow from Investing | -11.52M |
| Net Cash Flow from Operations | -5.65M |
| Effect of Exchange Rate Changes on Cash | -2.71M |
| Share Based Compensation | 7.19M |